Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-7,100
Closed -$1.44M 147
2018
Q3
$1.44M Hold
7,100
0.09% 114
2018
Q2
$1.3M Sell
7,100
-1,900
-21% -$339K 0.11% 110
2018
Q1
$1.52M Sell
9,000
-13,000
-59% -$2.34M 0.15% 94
2017
Q4
$3.97M Sell
22,000
-34,700
-61% -$5.96M 0.41% 55
2017
Q3
$9.02M Buy
56,700
+4,900
+9% +$765K 0.94% 37
2017
Q2
$7.87M Buy
51,800
+9,200
+22% +$1.3M 0.93% 45
2017
Q1
$5.43M Buy
42,600
+26,200
+160% +$3.29M 0.72% 50
2016
Q4
$2.03M Hold
16,400
0.42% 62
2016
Q3
$1.89M Sell
16,400
-9,500
-37% -$1.11M 0.34% 79
2016
Q2
$3.16M Sell
25,900
-19,100
-42% -$2.19M 0.6% 53
2016
Q1
$5.06M Buy
+45,000
New +$4.82M 0.92% 41

Other funds holding AET

Bellevue Group's AET Position: Q4 2018 in Review

Bellevue Group sold out of Aetna Inc (AET) in Q4 2018, closing a stake of 7,100 shares — an estimated $1.44M sold.

Bellevue Group first reported a position in AET in Q1 2016 and held it in 11 quarters. The position peaked at $9.02M in Q3 2017. 6 funds tracked by Wall St. Rank hold AET as of Q4 2018.

  • Bellevue Group reported no remaining Aetna Inc position as of Q4 2018 after selling out during the quarter.
  • Bellevue Group sold 7,100 Aetna Inc shares in Q4 2018, an estimated $1.44M.
  • Bellevue Group first reported a position in Aetna Inc in Q1 2016 and held it in 11 quarters.
  • Bellevue Group's Aetna Inc position peaked at $9.02M in Q3 2017.
  • 6 funds tracked by Wall St. Rank held Aetna Inc as of Q4 2018.

Based on Bellevue Group's 13F filing for Q4 2018, filed 12 Feb 2019.